+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

Vascular Ehlers Danlos Syndrome Market - Product Thumbnail Image

Vascular Ehlers Danlos Syndrome Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Intracerebral Hemorrhage Market - Product Thumbnail Image

Intracerebral Hemorrhage Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Brain Ischemia Market - Product Thumbnail Image

Brain Ischemia Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Telmisartan Market Report and Forecast 2024-2032 - Product Thumbnail Image

Telmisartan Market Report and Forecast 2024-2032

  • Report
  • October 2024
  • 200 Pages
  • Global
From
Cardiac Troponin Market Report and Forecast 2024-2032 - Product Thumbnail Image

Cardiac Troponin Market Report and Forecast 2024-2032

  • Report
  • September 2024
  • 200 Pages
  • Global
From
Giant Cell Arteritis Treatment Market Report and Forecast 2024-2032 - Product Thumbnail Image

Giant Cell Arteritis Treatment Market Report and Forecast 2024-2032

  • Report
  • September 2024
  • 250 Pages
  • Global
From
From
Cardiotoxicity Market Report and Forecast 2024-2032 - Product Thumbnail Image

Cardiotoxicity Market Report and Forecast 2024-2032

  • Report
  • July 2024
  • 200 Pages
  • Global
From
From
Abdominal Aortic Aneurysm - Pipeline Insight, 2025 - Product Thumbnail Image

Abdominal Aortic Aneurysm - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Advanced Heart Failure - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Heart Failure - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Acute Heart Failure - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Heart Failure - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 65 Pages
  • Global
From
Hypertrophic Cardiomyopathy- Pipeline Insight, 2025 - Product Thumbnail Image

Hypertrophic Cardiomyopathy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hypercholesterolaemia - Pipeline Insight, 2025 - Product Thumbnail Image

Hypercholesterolaemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Cholesterol Absorption Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cholesterol Absorption Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
VAP-1 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

VAP-1 Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Angiopoietin Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Angiopoietin Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Beta Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Beta Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Angiotensin Modulators - Pipeline Insight, 2025 - Product Thumbnail Image

Angiotensin Modulators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more